TNF-α and the development of the neonatal immune system: Implications for inhibitor use in pregnancy

American Journal of Gastroenterology

Volumn 106, Issue 4, 2011, Pages 559-562

  Arsenescu, Razvan ^a   Arsenescu, Violeta ^a   De Villiers, Willem J S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; GOLIMUMAB; IMMUNOGLOBULIN G ANTIBODY; LYMPHOTOXIN ALPHA BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BLOOD PLACENTA BARRIER; CELLULAR IMMUNITY; CROHN DISEASE; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNE SYSTEM DEVELOPMENT; INNATE IMMUNITY; LYMPH NODE; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PASSIVE IMMUNIZATION; PEYER PATCH; PHENOTYPE; POSTNATAL DEVELOPMENT; PREGNANCY; PREMATURITY; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; ULCERATIVE COLITIS;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; ANTIBODIES, MONOCLONAL; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; IMMUNE SYSTEM; MICE; PRIMATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953795330     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.5     Document Type: Article

References (30)

1. Dignass AU, Hartmann F, Sturm A et al. Management of infammatory bowel diseases during pregnancy. Dig Dis 2009;27:341-6.
2. Cassina M, Fabris L, Okolicsanyi L et al. Terapy of infammatory bowel diseases in pregnancy and lactation. Expert Opin Drug Saf 2009;8:695-707.
3. Aggarwal BB, Shishodia S, Ashikawa K et al Te role of TNF and its fam-ily members in infammation and cancer: lessons from gene deletion. Curr Drug Targets Infamm Allergy 2002;1:327-41.
4. Flavell RA. Te relationship of infammation and initiation of autoim-mune disease: role of TNF super family members. Curr Top Microbiol Immunol 2002;266:1-9. (Pubitemid 34297385)
5. Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 2000;50:184-95. (Pubitemid 30610095)
6. Spahn TW, Kucharzik T Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut 2004;53:456-65. (Pubitemid 38241347)
7. McDevitt H, Munson S, Ettinger R et al Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity. Arthritis Res 2002;4(Suppl 3):S141-52.
8. Szepfalusi Z. Te maturation of the fetal and neonatal immune system. J Nutr 2008;138:1773S-81S.
9. Makhseed M, Raghupathy R, Azizieh F et al T1 and T2 cytokine pro-fles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001;16:2219-26. (Pubitemid 32951921)
10. Challis JR, Lockwood CJ, Myatt L et al. Infammation and pregnancy Reprod Sci 2009;16:206-15.
11. Pasparakis M, Alexopoulou L, Episkopou V et al Immune and infam-matory responses in TNF alpha-defcient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-411. (Pubitemid 26354696)
12. Neumann B, Luz A, Pfefer K et al Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med 1996;184:259-64. (Pubitemid 26247235)
13. Matsumoto M, Mariathasan S, Nahm MH et al. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 1996;271:1289-91. (Pubitemid 26082651)
14. Tiron A, Vasilescu C. Role of the spleen in immunity. Immunologic con-sequences of splenectomy Chirurgia (Bucur) 2008;103:255-63.
15. Wen L, Shinton SA, Hardy RR et al Association of B-1 B cells with fol-licular dendritic cells in spleen. J Immunol 2005;174:6918-26. (Pubitemid 40705656)
16. Martin PL, Oneda S, Treacy G. Efects of an anti-TNF-alpha monoclo-nal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system. Am J Reprod Immunol 2007;58:138-49. (Pubitemid 47097380)
17. Tel Mourabet M, El-Hachem S, Harrison JR et al. Anti-TNF antibody therapy for infammatory bowel disease during pregnancy: a clinical review. Curr Drug Targets 2010;11:234-41.
18. Kim J, Mohanty S, Ganesan LP et al. FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus. J Immunol 2009;182:2583-9.
19. Malek A, Sager R, Schneider H. Maternal-fetal transport of immunoglob-ulin G and its subclasses during the third trimester of human pregnancy Am J Reprod Immunol 1994;32:8-14. (Pubitemid 24230567)
20. Brandtzaeg P Te mucosal immune system and its integration with the mammary glands. J Pediatr 2010;156(Suppl):S8-15.
21. Dijkstra CD, Dopp EA. Ontogenetic development of T-and B-lympho-cytes and non-lymphoid cells in the white pulp of the rat spleen. Cell Tissue Res 1983;229:351-63. (Pubitemid 13127762)
22. Holsapple MP, West LJ, Landreth KS. Species comparison of anatomical and functional immune system development. Birth Defects Res B Dev Reprod Toxicol 2003;68:321-34. (Pubitemid 37238421)
23. Bossen C, Ingold K, Tardivel A et al Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem 2006;281:13964-71. (Pubitemid 43848322)
24. Aaltonen R, Heikkinen T, Hakala K et al Transfer of proinfammatory cytokines across term placenta. Obstet Gynecol 2005;106:802-7. (Pubitemid 41362186)
25. Shapiro R, Beatty DW, Woods DL et al Serum complement and immuno-globulin values in small-for-gestational-age infants. J Pediatr 1981;99:139-41. (Pubitemid 11046440)
26. Peyrin-Biroulet L. Anti-TNF therapy in infammatory bowel diseases: a huge review. Minerva Gastroenterol Dietol 2010;56:233-43.
27. Sandborn WJ, Hanauer SB, Katz S et al Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroen-terology 2001;121:1088-94. (Pubitemid 33022088)
28. Dinesen L, Travis S. Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). Int J Nanomedicine 2007;2:39-47. (Pubitemid 46901780)
29. Connan K, Kornman L, Savoia H et al IVIG: is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloim-munisation during pregnancy: a case series. Aust N Z J Obstet Gynaecol 2009;49:612-8.
30. Sapir T, Carp H, Shoenfeld Y. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)] (article in Hebrew). Harefuah 2005;144:415-20. (Pubitemid 41726337)